ALZAMEND NEURO Trademark

Trademark Overview

On Wednesday, June 29, 2022, a trademark application was filed for ALZAMEND NEURO with the United States Patent and Trademark Office. The USPTO has given the ALZAMEND NEURO trademark a serial number of 97482166. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, July 10, 2024. This trademark is owned by Alzamend Neuro, Inc.. The ALZAMEND NEURO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases
alzamend neuro

General Information

Serial Number97482166
Word MarkALZAMEND NEURO
Filing DateWednesday, June 29, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, July 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases
NOT AVAILABLE"NEURO"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlzamend Neuro, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30326
Party NameAlzamend Neuro, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30326

Trademark Events

Event DateEvent Description
Thursday, April 13, 2023EXAMINERS AMENDMENT E-MAILED
Saturday, July 2, 2022NEW APPLICATION ENTERED
Tuesday, July 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 12, 2023ASSIGNED TO EXAMINER
Thursday, April 13, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, April 13, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 13, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, April 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 11, 2024SOU EXTENSION 1 FILED
Thursday, January 11, 2024SOU EXTENSION 1 GRANTED
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024DIVISIONAL REQUEST RECEIVED
Thursday, January 25, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, February 5, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 6, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, July 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2024SOU EXTENSION 2 FILED
Wednesday, July 10, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 7, 2024CORRECTED NOA E-MAILED

Related Keywords

neuro alzamend neurological disorders diseases psychiatric treatment preparations substances pharmaceutical